NCT05708677View on ClinicalTrials.gov

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Enrolling by invitationOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

February 29, 2036

Study Completion Date

August 31, 2036

Conditions
RDEB
Interventions
BIOLOGICAL

EB-101

This is non-interventional and follows patients treated with EB-101

Trial Locations (2)

94063

Stanford University, Redwood City

01605

University of Massachusetts Medical School, Worcester

Sponsors
All Listed Sponsors
lead

Abeona Therapeutics, Inc

INDUSTRY

NCT05708677 - A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB | Biotech Hunter | Biotech Hunter